Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes.

Schludi B, Moin ASM, Montemurro C, Gurlo T, Matveyenko AV, Kirakossian D, Dawson DW, Dry SM, Butler PC, Butler AE.

JCI Insight. 2017 Jul 6;2(13). pii: 92282. doi: 10.1172/jci.insight.92282. [Epub ahead of print]

2.

Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.

McAllister F, Montiel MF, Uberoi GS, Uberoi AS, Maitra A, Bhutani MS.

Gastroenterol Hepatol (N Y). 2017 May;13(5):268-275.

3.

Pancreatic Cancer Heralded by Worsening Glycemic Control: A Report of Two Cases.

Desai D, Rao D, Sukrithan V, Weinstein E, Goyal A, Schubart U.

J Investig Med High Impact Case Rep. 2017 Jun 8;5(2):2324709617714286. doi: 10.1177/2324709617714286. eCollection 2017 Apr-Jun.

4.

Joint L1/2-Norm Constraint and Graph-Laplacian PCA Method for Feature Extraction.

Feng CM, Gao YL, Liu JX, Wang J, Wang DQ, Wen CG.

Biomed Res Int. 2017;2017:5073427. doi: 10.1155/2017/5073427. Epub 2017 Apr 2.

5.

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.

Zhou PT, Li B, Liu FR, Zhang MC, Wang Q, Li YY, Xu C, Liu YH, Yao Y, Li D.

Oncotarget. 2017 Apr 11;8(15):25242-25250. doi: 10.18632/oncotarget.15692.

6.

Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.

He X, Zhong J, Wang S, Zhou Y, Wang L, Zhang Y, Yuan Y.

Oncotarget. 2017 Apr 25;8(17):29116-29124. doi: 10.18632/oncotarget.16249.

7.

High Glucose Accelerates Cell Proliferation and Increases the Secretion and mRNA Expression of Osteopontin in Human Pancreatic Duct Epithelial Cells.

Ito M, Makino N, Matsuda A, Ikeda Y, Kakizaki Y, Saito Y, Ueno Y, Kawata S.

Int J Mol Sci. 2017 Apr 12;18(4). pii: E807. doi: 10.3390/ijms18040807.

8.

Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Hart PA, Bellin MD, Andersen DK, Bradley D, Cruz-Monserrate Z, Forsmark CE, Goodarzi MO, Habtezion A, Korc M, Kudva YC, Pandol SJ, Yadav D, Chari ST; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer(CPDPC).

Lancet Gastroenterol Hepatol. 2016 Nov;1(3):226-237. doi: 10.1016/S2468-1253(16)30106-6. Epub 2016 Oct 12. Review.

9.

Effect of Metformin on Different Non-Diabetes Related Conditions, a Special Focus on Malignant Conditions: Review of Literature.

Abdelgadir E, Ali R, Rashid F, Bashier A.

J Clin Med Res. 2017 May;9(5):388-395. doi: 10.14740/jocmr2922e. Epub 2017 Apr 1. Review.

10.

Obesity, Diabetes and Cancer: A Mechanistic Perspective.

Cifarelli V, Hursting SD.

Int J Diabetol Vasc Dis Res. 2015;2015(Suppl 4). doi: 10.19070/2328-353X-SI04001. Epub 2015 Sep 28.

11.

Type 2 diabetes mellitus is associated with increased risk of pancreatic cancer: A veteran administration registry study.

Makhoul I, Yacoub A, Siegel E.

SAGE Open Med. 2016 Dec 14;4:2050312116682257. doi: 10.1177/2050312116682257. eCollection 2016.

12.

Diabetes in HFE Hemochromatosis.

Barton JC, Acton RT.

J Diabetes Res. 2017;2017:9826930. doi: 10.1155/2017/9826930. Epub 2017 Feb 26. Review.

13.

Familial pancreatic cancer: Concept, management and issues.

Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T.

World J Gastroenterol. 2017 Feb 14;23(6):935-948. doi: 10.3748/wjg.v23.i6.935. Review.

14.

Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies.

Pang Y, Kartsonaki C, Guo Y, Bragg F, Yang L, Bian Z, Chen Y, Iona A, Millwood IY, Lv J, Yu C, Chen J, Li L, Holmes MV, Chen Z.

Int J Cancer. 2017 Apr 15;140(8):1781-1788. doi: 10.1002/ijc.30599. Epub 2017 Feb 8.

15.

Epidemiology of pancreatic cancer.

Ilic M, Ilic I.

World J Gastroenterol. 2016 Nov 28;22(44):9694-9705. Review.

16.

Pancreatic Cancer: A Survival Analysis Study in Oklahoma.

Wahutu M, Vesely SK, Campbell J, Pate A, Salvatore AL, Janitz AE.

J Okla State Med Assoc. 2016 Jul-Aug;109(7-8):391-398.

17.

Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study.

Balzano G, Dugnani E, Gandolfi A, Scavini M, Pasquale V, Aleotti F, Liberati D, Di Terlizzi G, Petrella G, Reni M, Doglioni C, Bosi E, Falconi M, Piemonti L.

PLoS One. 2016 Nov 4;11(11):e0166008. doi: 10.1371/journal.pone.0166008. eCollection 2016.

18.

Epigenetic alterations in patients with type 2 diabetes mellitus.

Karachanak-Yankova S, Dimova R, Nikolova D, Nesheva D, Koprinarova M, Maslyankov S, Tafradjiska R, Gateva P, Velizarova M, Hammoudeh Z, Stoynev N, Toncheva D, Tankova T, Dimova I.

Balkan J Med Genet. 2016 Jul 9;18(2):15-24. eCollection 2015 Dec 1.

19.

Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.

Biernacka KM, Persad RA, Bahl A, Gillatt D, Holly JM, Perks CM.

Endocr Relat Cancer. 2017 Jan;24(1):17-30. Epub 2016 Oct 17.

20.

Association between selenium intake and the risk of pancreatic cancer: a meta-analysis of observational studies.

Wang L, Wang J, Liu X, Liu Q, Zhang G, Liang L.

Biosci Rep. 2016 Oct 14;36(5). pii: e00395. Print 2016 Oct.

Supplemental Content

Support Center